Faster, cheaper scans could revolutionize cancer radiation planning

NCT ID NCT07185958

Not yet recruiting Diagnosis Sponsor: Aalborg University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will test whether a special CT scan (dual-energy CT) can be as good as MRI for mapping tumors and healthy organs before radiation therapy. Researchers will enroll 80 people with brain, bone, head/neck, or lung cancer. If DECT works well, it could save time and money compared to MRI.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dual-energy CT (DECT) scan and iodine-based contrast agent
What this could lead to: If successful, DECT could become a faster, cheaper alternative to MRI for planning radiotherapy, improving access and efficiency.
What could go wrong: This is an early-stage study with only 80 participants, and DECT may not prove as accurate as MRI for all tumor types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer head and neck cancer Head and Neck Neoplasms lung cancer lung neoplasm metastatic carcinoma in the bone metastatic malignant neoplasm in the brain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE METASTASES BRAIN METASTASES HEAD AND NECK CANCER LUNG CANCER

Contacts and locations

Locations

Aalborg University Hospital

Aalborg, 9000, Denmark
Copenhagen University Hospital Herlev and Gentofte

Herlev, 2730, Denmark
Odense University Hospital

Odense, 5000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.